Form4insider filings, from the source

SEC Form 4 · accession 0001213900-16-013967

Karyopharm Therapeutics Inc. · KPTI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Chione Ltd
10% Owner
Period of report
May 27, 2016
Accepted (ET)
Jun 1, 2016 · 8:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
COMMON STOCKF1,F2,F3,F4,F5May 27, 2016S40,000$9.58D8,713,878D
COMMON STOCKF1,F2,F3,F4,F5May 31, 2016S17,096$9.6556D8,696,782D
COMMON STOCKF1,F2,F3,F4,F5Jun 1, 2016S17,568$9.6384D8,679,214D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Exhibit Index Exhibit 24.1 - Power of Attorney, dated May 12, 2016, made by Marcin Czernik and Chione Limited in favor of Simon Prisk (previously filed) Exhibit 24.2 - Power of Attorney, dated May 12, 2016, made by Andreas Hadjimichael and Chione Limited in favor of Simon Prisk (previously filed) Exhibit 24.3 - Power of Attorney, dated February 15, 2016, made by George Hadjimichael and Chione Limited in favor of Simon Prisk (previously filed) Exhibit 24.4 - Power of Attorney, dated May 12, 2016, made by Wiaczeslaw Smolokowski in favor of Simon Prisk Exhibit (previously filed) 99.1 - Joint Filer Information (filed herewith) Exhibit 99.2 - Joint Filing Agreement (previously filed). All previously filed Exhibits were filed with the Form 4 of the reporting persons, filed on May 12, 2016, except that Exhibit 24.3 was filed with the Schedule 13G/A of the reporting persons, filed on March 9, 2016.